Clinical Trial Update: Mechanisms of Resistance to PSMA Radioligand Therapy

View source ↗

Summary

A UCSF-sponsored clinical trial is studying mechanisms of resistance to PSMA radioligand therapy in prostate cancer. The work aims to understand why some patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Lutetium-177 PSMA-617 (lutetium Lu-177 PSMA-617)

Snippet

Sponsor: University of California, San Francisco | Conditions: Prostate Cancer | Status: RECRUITING